Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -253.78%-10.07M | ---- | -11.17%6.55M | ---- | 92.18%7.37M | ---- | 181.68%3.83M | ---- | -219.44%-4.69M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -76.60%-1.02M | ---- | -679.73%-577K | ---- | -335.29%-74K | ---- | 66.67%-17K | ---- | 1.92%-51K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 23.44%-356K | ---- | 62.20%-465K | ---- | -345.02%-1.23M | ---- | 996.43%502K |
| Impairment and provisions: | ---- | -6.39%3.56M | ---- | 168.69%3.8M | ---- | -49.55%1.42M | ---- | -16.79%2.81M | ---- | 1,837.36%3.37M |
| -Impairment of trade receivables (reversal) | ---- | 11.32%413K | ---- | 198.93%371K | ---- | -168.81%-375K | ---- | -83.83%545K | ---- | 1,837.36%3.37M |
| -Impairment of goodwill | ---- | -8.31%3.15M | ---- | 91.68%3.43M | ---- | -20.80%1.79M | ---- | --2.26M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -111.84%-322K | ---- | ---152K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -111.84%-322K | ---- | ---152K |
| Asset sale loss (gain): | ---- | 100.68%42K | ---- | -36,494.12%-6.19M | ---- | -95.47%17K | ---- | 650.00%375K | ---- | -93.12%50K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---6.39M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 1,300.00%42K | ---- | -82.35%3K | ---- | -95.47%17K | ---- | 504.84%375K | ---- | -91.47%62K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | --198K | ---- | ---- | ---- | ---- | ---- | ---12K |
| Depreciation and amortization: | ---- | -7.83%11.48M | ---- | -9.64%12.45M | ---- | -7.47%13.78M | ---- | 3.96%14.89M | ---- | 75.88%14.33M |
| -Amortization of intangible assets | ---- | -71.11%325K | ---- | -1.23%1.13M | ---- | 22.60%1.14M | ---- | 255.94%929K | ---- | 314.29%261K |
| Financial expense | ---- | 38.27%961K | ---- | -0.14%695K | ---- | -58.67%696K | ---- | -45.97%1.68M | ---- | 99.94%3.12M |
| Special items | ---- | 148.54%1.02M | ---- | --410K | ---- | ---- | ---- | ---- | ---- | -90.32%12K |
| Operating profit before the change of operating capital | ---- | -64.40%5.98M | ---- | -26.18%16.79M | ---- | 3.25%22.74M | ---- | 33.62%22.02M | ---- | 13.26%16.48M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 55.58%6.7M | ---- | 99.21%4.31M | ---- | 124.91%2.16M | ---- | -216.69%-8.68M | ---- | 176.79%7.44M |
| Accounts payable increase (decrease) | ---- | -183.65%-1.45M | ---- | 161.67%1.73M | ---- | -243.95%-2.81M | ---- | 129.87%1.95M | ---- | -52.99%-6.53M |
| Special items for working capital changes | ---- | -192.51%-11.46M | ---- | 362.72%12.39M | ---- | -188.27%-4.72M | ---- | 239.45%5.34M | ---- | 599.56%1.57M |
| Cash from business operations | ---- | -100.66%-231K | ---- | 102.63%35.22M | ---- | -15.77%17.38M | ---- | 8.78%20.63M | ---- | 43.72%18.97M |
| Other taxs | ---- | 81.15%-206K | ---- | -614.38%-1.09M | ---- | -116.79%-153K | ---- | 147.80%911K | ---- | -389.67%-1.91M |
| Special items of business | 151.48%3.16M | ---- | -212.96%-6.13M | ---- | -31.89%5.43M | ---- | 27.25%7.97M | ---- | 376.85%6.26M | ---- |
| Net cash from operations | 151.48%3.16M | -101.28%-437K | -212.96%-6.13M | 98.08%34.12M | -31.89%5.43M | -20.05%17.23M | 27.25%7.97M | 26.27%21.55M | 376.85%6.26M | 23.14%17.06M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 76.60%1.02M | ---- | 679.73%577K | ---- | 335.29%74K | ---- | -66.67%17K | ---- | -1.92%51K |
| Decrease in deposits (increase) | ---- | ---- | ---- | 397.24%1.51M | ---- | ---507K | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | 1,800.00%19K | ---- | -90.00%1K | ---- | --10K | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | -831.50%-9.32M | ---- | 5.57%-1M | ---- | 10.25%-1.06M | ---- | -114.55%-1.18M | ---- | 69.00%-550K |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --620K |
| Purchase of intangible assets | ---- | -115.00%-129K | ---- | 89.69%-60K | ---- | 10.46%-582K | ---- | 72.77%-650K | ---- | -616.82%-2.39M |
| Sale of subsidiaries | ---- | ---- | ---- | --16.45M | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---1.91M | ---- | ---- | ---- | -90.56%259K | ---- | --2.75M |
| Other items in the investment business | 98.70%-102K | ---- | -178.77%-7.87M | ---- | 49.28%-2.82M | ---- | -223.49%-5.56M | ---- | 65.55%-1.72M | ---4.3M |
| Net cash from investment operations | 98.70%-102K | -153.98%-8.41M | -178.77%-7.87M | 854.41%15.57M | 49.28%-2.82M | -32.82%-2.06M | -223.49%-5.56M | 59.36%-1.55M | 65.55%-1.72M | -45.90%-3.82M |
| Net cash before financing | 121.81%3.05M | -117.80%-8.84M | -637.48%-14M | 227.75%49.69M | 8.36%2.6M | -24.16%15.16M | -47.08%2.4M | 51.01%19.99M | 223.40%4.54M | 17.83%13.24M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | --2.62M | ---- | ---- | ---- | ---- |
| Refund | ---- | 67.67%-215K | ---- | 68.14%-665K | ---- | ---2.09M | ---- | ---- | ---- | ---12.71M |
| Interest paid - financing | ---- | -38.27%-961K | ---- | 0.14%-695K | ---- | 58.67%-696K | ---- | 45.97%-1.68M | ---- | -99.94%-3.12M |
| Dividends paid - financing | ---- | -33.33%-8.43M | ---- | -110.70%-6.32M | ---- | ---3M | ---- | ---- | ---- | ---- |
| Other items of the financing business | 81.79%-2.65M | ---- | -241.74%-14.58M | ---- | 40.42%-4.27M | ---485K | -4.74%-7.16M | ---- | -18.54%-6.83M | ---- |
| Net cash from financing operations | 81.79%-2.65M | 2.31%-17.15M | -241.74%-14.58M | -13.27%-17.55M | 40.42%-4.27M | -15.52%-15.5M | -4.74%-7.16M | 48.73%-13.42M | -18.54%-6.83M | -456.07%-26.16M |
| Effect of rate | -17,000.00%-169K | 112.84%19K | 100.69%1K | -886.67%-148K | ---145K | 34.78%-15K | ---- | -228.57%-23K | ---- | -130.43%-7K |
| Net Cash | 101.40%399K | -180.87%-25.99M | -1,620.11%-28.57M | 9,693.73%32.14M | 65.07%-1.66M | -105.09%-335K | -107.37%-4.76M | 150.88%6.58M | 75.72%-2.29M | -297.93%-12.93M |
| Begining period cash | -28.68%64.6M | 54.61%90.58M | 54.61%90.58M | -0.59%58.59M | -0.59%58.59M | 12.51%58.94M | 12.51%58.94M | -19.80%52.38M | -19.80%52.38M | 11.15%65.31M |
| Cash at the end | 4.56%64.83M | -28.68%64.6M | 9.21%62.01M | 54.61%90.58M | 4.80%56.78M | -0.59%58.59M | 8.17%54.18M | 12.51%58.94M | -10.35%50.09M | -19.80%52.38M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -19.80%52.38M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -19.80%52.38M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.